Nobutaka Nagai
Department of Obstetrics and Gynecology
Hiroshima University School of Medicine
Minami-ku
Hiroshima 734-8551
Japan
Name/email consistency: high
- Predicting the chemosensitivity of ovarian and uterine cancers with the collagen gel droplet culture drug-sensitivity test. Nagai, N., Minamikawa, K., Mukai, K., Hirata, E., Komatsu, M., Kobayashi, H. Anticancer. Drugs (2005)
- Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade III - A prospective study. Nagai, N., Mukai, K., Oshita, T., Shiroyama, Y., Ohama, K. Int. J. Mol. Med. (2004)
- Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy. Nagai, N., Tian, X., Mukai, K., Hirata, E., Kusuda, T., Shiroyama, Y., Shigemasa, K., Ohama, K. Int. J. Mol. Med. (2003)
- Endometrial cytodiagnosis using a new softcyte versus a conventional endocyte. Nagai, N., Uebaba, Y., Oshita, T., Sakata, K., Murakami, J., Shigemasa, K., Ohama, K. Oncol. Rep. (2002)
- GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells. Nagai, N., Oshita, T., Mukai, K., Shiroyama, Y., Shigemasa, K., Ohama, K. Int. J. Mol. Med. (2002)